Engineers Gate Manager LP Agios Pharmaceuticals, Inc. Transaction History
Engineers Gate Manager LP
- $4.27 Billion
- Q2 2024
A detailed history of Engineers Gate Manager LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 25,806 shares of AGIO stock, worth $1.15 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,806
Previous 36,570
29.43%
Holding current value
$1.15 Million
Previous $1.07 Million
4.02%
% of portfolio
0.03%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$251 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$216 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$172 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$123 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.44B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...